Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | F13A1 | P00488 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11137669 | 0.98 | TMEM97 (0.59) | TMEM97SIGMAR1KDM4EF13A1ESR1 | |
| Sulfuric Acid SCHEMBL32684873 | 0.91 | TMEM97 (0.52) | TMEM97SIGMAR1KDM4EF13A1ESR1 | |
| SCHEMBL30852242 | 0.80 | TMEM97 (0.57) | TMEM97SIGMAR1KDM4EF13A1ESR1 | |
| SCHEMBL6077274 | 0.79 | TAAR1 (0.61) | LMNAALDH1A1TAAR1L3MBTL1 | |
| Hydroquinone SCHEMBL11034414 | 0.78 | CA12 (0.40) | TMEM97SIGMAR1KDM4EESR1ESR2 | |
| SCHEMBL388472 | 0.78 | ATM (0.58) | SIGMAR1SLC6A2LMNACYP2D6ADRA1A | |
| Hydrochloric Acid SCHEMBL31220079 | 0.77 | MAPT (0.66) | SIGMAR1KDM4ECA2SLC6A2SLC6A4 | |
| Iodide SCHEMBL28805506 | 0.77 | ATM (0.56) | SIGMAR1SLC6A2LMNACYP2D6ADRA1A | |
| SCHEMBL274906 | 0.76 | TMEM97 (1.00) | TMEM97SIGMAR1KDM4EF13A1ESR1 | |
| SCHEMBL28451160 | 0.75 | ALDH1A1 (0.45) | KDM4ELMNACYP2D6ALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-05-28 | — | — | US | claimed |
| CN-120195313-A | Rapid screening method and screening database for food-borne stimulants in racing foods based on high-throughput technology | 成都市食品检验研究院 | 2025-06-24 | — | — | CN | claimed |
| EP-4562182-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2025-06-04 | — | — | EP | claimed |
| CN-114428138-B | Catecholamine and metabolite liquid chromatography tandem mass spectrometry detection method based on magnetic solid phase extraction | 天津国科医疗科技发展有限公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2024023324-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2024-02-01 | — | — | WO | claimed |
| CN-116794168-A | Method for detecting methoxytyramine in dairy product | 内蒙古伊利实业集团股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-114428138-A | Liquid chromatography tandem mass spectrometry detection method of catecholamine and metabolites thereof based on magnetic solid phase extraction | 天津国科医工科技发展有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-112305104-A | Method for determining residual quantity of 36 veterinary drugs in livestock meat | 普研（上海）标准技术服务股份有限公司 | 2021-02-02 | — | — | CN | claimed |
| CN-107462647-A | Pheochromocytoma diagnostic kit and its application method | 重庆医科大学 | 2017-12-12 | — | — | CN | claimed |
| CN-105699565-B | Detect the method and liquid matter database of left drug in animal-derived food | 山东出入境检验检疫局检验检疫技术中心 | 2017-09-22 | — | — | CN | claimed |
| CN-104880529-B | Detect method and the liquid matter data base of left drug in animal-derived food | 山东出入境检验检疫局检验检疫技术中心 | 2016-08-31 | — | — | CN | claimed |
| CN-105699565-A | Method and liquid-mass database for detecting residual drugs in animal-derived food | 山东出入境检验检疫局检验检疫技术中心 | 2016-06-22 | — | — | CN | claimed |
| CN-104880529-A | Method and liquid mass database for detecting chemical residues in animal-derived food | SHANDONG TECHNICAL CT INSPECTION & QUARANTINE | 2015-09-02 | — | — | CN | claimed |
| US-20100105076-A1 | ANALYSIS KIT COMPRISING AT LEAST TWO MOLECULARLY IMPRINTED POLYMERS AND AT LEAST ONE MARKER, AND METHOD OF ANALYSIS USING SAME | POLYINTELL (FR) | 2010-04-29 | — | — | US | claimed |
| EP-2125195-A2 | ANALYSIS KIT COMPRISING AT LEAST TWO MOLECULARLY IMPRINTED POLYMERS AND AT LEAST ONE MARKER, AND METHOD OF ANALYSIS USING SAME | Polyintell (FR) | 2009-12-02 | — | — | EP | claimed |
| WO-2008132384-A2 | ANALYSIS KIT COMPRISING AT LEAST TWO MOLECULARLY IMPRINTED POLYMERS AND AT LEAST ONE MARKER, AND METHOD OF ANALYSIS USING SAME | POLYINTELL (FR) | 2008-11-06 | — | — | WO | claimed |
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-05-28 | — | — | US | disclosed |
| US-12409163-B2 | Method of enhancing 5-hydroxytryptophan (5-HTP) exposure | EVECXIA THERAPEUTICS, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-4242456-A | METHYLATION USING CATECHOL-O-METHYL TRANSFERASE AND A LABELED-METHYL DONOR | THE UPJOHN COMPANY (US) | 1980-12-30 | — | — | US | disclosed |
| US-4242222-A | VANILLIN LABELED WITH TRITIUM, WATER, ACID | THE UPJOHN COMPANY (US) | 1980-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | SHBG, HSD11B2, HSD11B1 | TMEM97 4813/4885SIGMAR1 4429/4885KDM4E 2264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.